Literature DB >> 1202089

Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.

R W Colman, A Bagdasarian, R C Talamo, C F Scott, M Seavey, J A Guimaraes, J V Pierce, A P Kaplan.   

Abstract

An asymptomatic woman (Ms. Williams) was found to have a severe abnormality in the surface-activated intrinsic coagulation, fibrinolytic, and kinin-generating pathways. Assays for known coagulation factors were nromal while Fletcher factor (pre-kallikrein) was 45%, insufficient to account for the observed markedly prolonged partial thromboplastin time. Plasminogen proactivator was present at 20% of normal levels and addition of highly purified plasminogen proactivator containing 10% plasminogen activator partially corrected the coagulation and fibrinolytic abnormalities but not the kinin-generating defect. This effect was due to its plasminogen activator content. In addition, Williams trait plasma failed to convert prekallilrein to lakkilrein or release kinin upon incubation with kaolin. Kininogen antigen was undetectable. When normal plasma was fractionated to identify the factor that corrects all the abnormalities in Williams trait plasma, the Williams factor was identified as a form of kininogen by its behavior on ion exchange chromatography, gel filtration, disc gel electrophoresis, and elution from an anti-low molecular weight kininogen immunoadsorbent. High molecular weight kininogen as well as a subfraction of low molecular weight kininogen, possessed this corrective activity while the bulk of low molecular weight kininogen functioned only as a kallikrein substrate. Kininogen therefore is a critical factor required for the functioning of Hageman factor-dependent coagulation and fibrinolysis and for the activation of prekallikrein.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1202089      PMCID: PMC333144          DOI: 10.1172/JCI108247

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.

Authors:  A S Weiss; J I Gallin; A P Kaplan
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  Congenital familial deficiency of factor V (parahaemophilia) combined with deficiency of antihaemophilic globulin.

Authors:  T IVERSEN; P BASTRUP-MADSEN
Journal:  Br J Haematol       Date:  1956-07       Impact factor: 6.998

3.  Christmas disease associated with factor VII deficiency; case report with family survey.

Authors:  W N BELL; H G ALTON
Journal:  Br Med J       Date:  1955-02-05

4.  A one-stage method for the determination of accelerator globulin.

Authors:  M L LEWIS; A G WARE
Journal:  Proc Soc Exp Biol Med       Date:  1953-12

5.  New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor.

Authors:  R L ROSENTHAL; O H DRESKIN; N ROSENTHAL
Journal:  Proc Soc Exp Biol Med       Date:  1953-01

6.  Antigen-antibody reactions in gels. IV. Types of reactions in coordinated systems of diffusion.

Authors:  O OUCHTERLONY
Journal:  Acta Pathol Microbiol Scand       Date:  1953

7.  Plasminogen: purification from human plasma by affinity chromatography.

Authors:  D G Deutsch; E T Mertz
Journal:  Science       Date:  1970-12-04       Impact factor: 47.728

8.  A pre-albumin activator of prekallikrein.

Authors:  A P Kaplan; K F Austen
Journal:  J Immunol       Date:  1970-10       Impact factor: 5.422

9.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

10.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

View more
  56 in total

1.  Turnover of human and monkey plasma kininogens in rhesus monkeys.

Authors:  T Yamada; D A Wing; J V Pierce; G W Pettit
Journal:  J Clin Invest       Date:  1979-01       Impact factor: 14.808

2.  Purification of high molecular weight kininogen and the role of this agent in blood coagulation.

Authors:  H Saito
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

3.  Kinetics of inhibition of platelet calpain II by human kininogens.

Authors:  H N Bradford; A H Schmaier; R W Colman
Journal:  Biochem J       Date:  1990-08-15       Impact factor: 3.857

4.  Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats.

Authors:  A Stadnicki; R B Sartor; R Janardham; I Stadnicka; A A Adam; C Blais; R W Colman
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

5.  Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.

Authors:  H L Meier; J V Pierce; R W Colman; A P Kaplan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

Review 6.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

7.  A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.

Authors:  Ricardo G Espinola; Audrey Uknis; Irma M Sainz; Irma Isordia-Salas; Robin Pixley; Raul DeLa Cadena; Walter Long; Alexis Agelan; John Gaughan; Albert Adam; Robert W Colman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Rapid purification of human high molecular weight kininogen.

Authors:  F M Habal; H Z Movat
Journal:  Agents Actions       Date:  1976-09

10.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases.

Authors:  G Salvesen; C Parkes; M Abrahamson; A Grubb; A J Barrett
Journal:  Biochem J       Date:  1986-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.